VYNE Therapeutics Files Q1 2025 10-Q
Ticker: VYNE · Form: 10-Q · Filed: May 8, 2025 · CIK: 1566044
| Field | Detail |
|---|---|
| Company | Vyne Therapeutics Inc. (VYNE) |
| Form Type | 10-Q |
| Filed Date | May 8, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, pharmaceutical
TL;DR
VYNE Therapeutics filed its Q1 2025 10-Q. Check financials.
AI Summary
VYNE Therapeutics Inc. filed its 10-Q for the period ending March 31, 2025. The filing details the company's financial performance and position as of that date. Key financial data and disclosures relevant to investors are presented in this report.
Why It Matters
This 10-Q filing provides investors with the latest financial snapshot of VYNE Therapeutics, crucial for understanding the company's current health and future prospects.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, VYNE Therapeutics is subject to inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 2025-03-31 — Reporting Period End Date (Indicates the end of the financial quarter being reported.)
- 2025-05-08 — Filing Date (The date the 10-Q was officially submitted to the SEC.)
Key Players & Entities
- VYNE Therapeutics Inc. (company) — Filer of the 10-Q
- 20250331 (date) — End of the reporting period
- 20250508 (date) — Filing date
- Menlo Therapeutics Inc. (company) — Former company name
- Tigercat Pharma, Inc. (company) — Former company name
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is the quarter ended March 31, 2025.
When was this 10-Q filed with the SEC?
This 10-Q was filed on May 8, 2025.
What was VYNE Therapeutics Inc. previously known as?
VYNE Therapeutics Inc. was formerly known as Menlo Therapeutics Inc. and also previously as Tigercat Pharma, Inc.
What is the Standard Industrial Classification code for VYNE Therapeutics Inc.?
The Standard Industrial Classification code for VYNE Therapeutics Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Where is VYNE Therapeutics Inc. located?
VYNE Therapeutics Inc. is located at 685 Route 202/206 N., Suite 301, Bridgewater, NJ 08807.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 8, 2025 regarding VYNE Therapeutics Inc. (VYNE).